Geron Plans to Present at Upcoming Investor Conferences

Rhea-AI Summary

Geron (Nasdaq: GERN) announced management presentations at investor conferences in May 2026. Presentations: Bank of America Healthcare Conference on May 12 at 4:35 p.m. ET in Las Vegas and a Stifel Virtual Targeted Oncology Forum presentation on May 20 at 12:00 p.m. ET. A live and archived audio webcast will be available via the company's Investors and Media website.

AI-generated analysis. Not financial advice.

News Market Reaction – GERN

+5.10%

2 alerts

+5.10% News Effect

-4.6% Trough Tracked

+$51M Valuation Impact

$1.06B Market Cap

0.1x Rel. Volume

On the day this news was published, GERN gained 5.10%, reflecting a notable positive market reaction. Argus tracked a trough of -4.6% from its starting point during tracking. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $51M to the company's valuation, bringing the market cap to $1.06B at that time.

Data tracked by StockTitan Argus on the day of publication.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

FOSTER CITY, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that members of the management team are scheduled to present at the following investor conferences:

• Bank of America Securities 2026 Healthcare Conference
  Presentation on Tuesday, May 12 at 4:35 p.m. ET in Las Vegas, NV

• 2026 Stifel Virtual Targeted Oncology Forum
  Virtual presentation on Wednesday, May 20 at 12:00 p.m. ET

A live and archived audio webcast of the conference call will be available from the Investors and Media section of the Company’s website at www.geron.com.

About Geron
Geron is a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer. Our first-in-class telomerase inhibitor RYTELO^® (imetelstat) is approved in the United States and the European Union for the treatment of certain adult patients with lower-risk myelodysplastic syndromes with transfusion dependent anemia. We are also conducting a pivotal Phase 3 clinical trial of imetelstat in JAK-inhibitor relapsed/refractory myelofibrosis, as well as studies in other hematologic malignancies. Inhibiting telomerase activity, which is increased in malignant stem and progenitor cells in the bone marrow, aims to potentially reduce proliferation and induce death of malignant cells. To learn more, visit www.geron.com or follow us on LinkedIn.

Investors and Media
Dawn Schottlandt
Senior Vice President, Investor Relations and Corporate Affairs
dschottlandt@geron.com

FAQ

When will Geron (GERN) present at the Bank of America 2026 Healthcare Conference?

Geron will present on Tuesday, May 12, 2026 at 4:35 p.m. ET. According to Geron, the presentation will occur in Las Vegas and include management remarks accessible via live audio webcast on the company's investor website.

How can investors watch Geron's (GERN) Stifel Virtual Targeted Oncology Forum presentation?

Investors can access a live audio webcast and archived replay on Geron's investor website. According to Geron, the virtual presentation is scheduled for Wednesday, May 20, 2026 at 12:00 p.m. ET and will be available from the Investors and Media section.

Where will Geron (GERN) host archived audio of its May 2026 investor presentations?

Archived audio will be posted on Geron's investor website in the Investors and Media section. According to Geron, both the Bank of America and Stifel presentation webcasts will be available as live streams and archived audio on their site.

Who from Geron (GERN) will present at the May 2026 investor conferences?

Geron said members of its management team are scheduled to present at both events. According to Geron, specific presenters and slide materials, if any, will be provided via the company's investor relations web pages around the presentation dates.

What topics will Geron (GERN) cover in the May 2026 investor presentations?

Geron will provide company updates and strategic information relevant to investors during the presentations. According to Geron, the management team presentations will focus on corporate developments related to the company's blood cancer programs and investor interests.